SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-031371
Filing Date
2008-02-14
Accepted
2008-02-14 16:03:10
Documents
5
Period of Report
2008-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17364
2 SETTLEMENT & ASSIGNMENT AGREEMENT dex101.htm EX-10.1 57522
3 PRESS RELEASE dex991.htm EX-99.1 6982
4 PRESS RELEASE dex992.htm EX-99.2 119665
5 GRAPHIC g26197clip_image002.jpg GRAPHIC 5211
  Complete submission text file 0001193125-08-031371.txt   210565
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 08615372
SIC: 2834 Pharmaceutical Preparations